TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Knowledge of the radiation treatment process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient-reported helpfulness of videos
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: average pain scores at rest in the PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worst pain scores at rest in the PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Van Bijsterveld score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DED symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical and serological features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in paranoia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major amputation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of Surgical Site Outcomes (SSOs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incremental cost per additional SGA neonate identified
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incremental cost per infant QALY gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative SCD-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Postpartum hemorrhage incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Intrauterine growth restriction incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Mean total pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to T10 dermatome block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximal sensorial block level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy of digital intervention components for binge eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-free remission (TFR) at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average cost per patient/cycle
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reaction times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: average number of health topics discussed
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Enjoyment of diet
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction in substance use consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Person‐centered goal attainment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reported ease of remembering to practice
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Specificity of artificial intelligence model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy rate of artificial intelligence model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of artificial intelligence model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of SCORAD total score at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPPB score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: freedom from aortic death
Endpoint domain: Mortality/survival
Primary endpoint: any aortic event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: first-time diagnosis of aortic aneurysm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Child health improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in reported social risks
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: ABG closure (<10 dB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: readiness to engage in end-of-life discussions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SSO rates
Endpoint domain: Adverse events/effects
Primary endpoint: satisfaction with the procedure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: MSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of lymph node metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: DNA methylation modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: AUC value of the CSNet model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of ABC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bystander interventions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of aggressive events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of severe aggressive events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of physical restraints due to aggression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OC tumor growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement in metabolic parameters monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: appropriate use of aspirin and other antithrombotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decrease in haematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage discharged by 1 PM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate (≥50% decrease of symptom severity on the HDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse rate within 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean HDRS scores after the ECT course
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fleiss' kappa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of chronic pain at 3, 6, and 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of endoscopic sinus surgery (ESS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maternal fasting insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cord blood C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cord blood leptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: ISNCSCI motor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCIM III functional outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WISCI II functional outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AES-C improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3MS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: IADL improvement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Hematoma clearance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of nerve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of affective and cognitive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for allocation of healthcare resources to children
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean fatigue grade
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: grade ≥2 neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: HCV testing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV antibody detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental cost effectiveness ratio (QALY)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mdIOP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ECOHIS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CARIES-QC scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of hunger
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recovery as assessed by computed tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GTA and CSA values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of having a rotator cuff tear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in beneficial effect of treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area of occlusal marks on crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total misdiagnosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exhaled CO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T2 time in the posterior annulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: L5/S1 apparent diffusion coefficients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVD height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IFX failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mucosal remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of PAEC
Endpoint domain: Adverse events/effects
Primary endpoint: 20% improvement in ACR criteria at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate increases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: UE-FM scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Traumatic Stress Scale 10 intensive part B score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ventricular rate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean heart rate after 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Modified ISTH major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive impairment discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MMSE values
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Confidence in sample collection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positivity rates for CIN2+ and CIN3+
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased high-density lipoproteins (HDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increased mental health status (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: glycemic health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hand hygiene compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dosage of remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum dosage of remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of severe pain during ablation
Endpoint domain: Adverse events/effects
Primary endpoint: ureteral injury rates
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment satisfaction (MSQ score)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Delayed postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: prescribing quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOA symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of dippers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum glucose levels during OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: time to kidney failure, sustained decrease in estimated glomerular filtration rate ≥40% from baseline, or renal death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in average Hb concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to Recovery Discharge (TRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of immediate adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the concentration–time curve of 4‐MAA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life of 4‐MAA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SVs/RPS dissection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SVs-related estimated blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: rate of dry patients at 1 month after nsRALP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual analogue scale (VAS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: immune function (NK cells, CD3 + T cells, CD4 + / CD8 + ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Best confirmed PSA decline (≥90% or to ≤0.2 ng/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glenosphere tilt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prosthesis-scapular neck angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative beta angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: learning achievement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: learning engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Use of KRT in cases of physician-perceived treatment futility
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Willingness to continue TTNS in the longer term
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of use and convenience of TTNS
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: semi-dynamic balance (total) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean GOALS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in patient knowledge about PMBR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean decayed tooth (dt) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Prevalence of early childhood caries (ECC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Concordance between physicians' and patients' answers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma palonosetron concentrations (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma elimination half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of worsening heart failure event or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Rate of postoperative delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPAR?/? mRNA expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of R-score (ROI-wall) in the PP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average improvement of hearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median tumor D98%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Susceptibility to availability bias
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent to diagnose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preoperative plan realization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference of bilateral combined offsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-care ability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Achieving mastery of the communication skill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of leg complaints
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: personal relationships
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: median inpatient antibiotic duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of model in distinguishing benign and malignant breast lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Overall treatment coverage of Praziquantel (PZQ) against SCH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Free triiodothyronine (FT3) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: mean change from baseline in ocular hypotensive activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary function test (PFT) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cytokine levels in serum and supernatant of PBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in PedsQoL 4.0 Generic Core Scales scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Co and Cr ion levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in size of hyperfluorescent areas on ICGA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of having persistent subretinal fluid on optical coherence tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical clearance rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: wound healing times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Perceived NETP risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived CTP risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median Progression-Free Survival (PFS) for non-central nervous system metastases
Endpoint domain: Mortality/survival
Primary endpoint: Median Progression-Free Survival (PFS) for central nervous system metastases
Endpoint domain: Mortality/survival
Primary endpoint: Mean pre-score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in physical stressors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of time-out compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of Alivecor®
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cannulation time at the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total puncture procedure duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes